View Author
dai: 070907862
scopus: 15734104200

Kirkels, W.J.

(Wim Kirkels)


patient cancer recurrence tumor bladder study mutation grade treatment prostate analysis survival tumour marker table progression carcinoma result resection urine bladder cancer stage prostate cancer chemotherapy disease tumours group fgfr 3 mutations urology rectal cancer response urothelial score radiotherapy van der kwast follow-up factor fgfr 3 mutation testicular rectal therapy oncol sample number signi european fgfr 3 metastase surgery system exenteration level month fgfr 3 status pathologist radiation bacillu trial rotterdam prognostic status diagnosis netherland eortc signi ficantly microsatellite value complication outcome department ficial bladder cancer calmette-guerin erectile dysfunction center dysfunction model erectile series lymph health




10 Most Recent Publications

Markers predicting response to bacillus Calmette-Guérin immunotherapy in high-risk bladder cancer patients: A systematic review (Article)
Zuiverloon, T.C.M. Nieuweboer, A.J.M. Vékony, H. Kirkels, W.J. Bangma, C.H. Zwarthoff, E.C.
2012-01-01
Diagnosis of testicular carcinoma in situ'(intratubular and microinvasive)' seminoma and embryonal carcinoma using direct enzymatic alkaline phosphatase reactivity on frozen histological sections (Article)
Stoop, J.A. Kirkels, W.J. Dohle, G.R. Gillis, A.J. Bakker, M.A. den Biermann, K. Oosterhuis, J.W. Looijenga, L.H.J.
2011-02-01
Molecular grade (FGFR3/MIB-1) and EORTC risk scores are predictive in primary non-muscle-invasive bladder cancer (Article)
Rhijn, B.W.G. van Zuiverloon, T.C.M. Vis, A.N. Radvanyi, F. Leenders, G.J. van Ooms, B.C.M. Kirkels, W.J. Lockwood, G.A.
2010-09-01
Cervical lymph node dissection for metastatic testicular cancer (Article)
Vledder, M.G. van Hage, J.A. van der Kirkels, W.J. Oosterhuis, J.W. Verhoef, C. Wilt, J.H.W. de
2010-06-01
The Pathologist's Mean Grade Is Constant and Individualizes the Prognostic Value of Bladder Cancer Grading (Article)
Rhijn, B.W.G. van Leenders, G.J. van Ooms, B.C.M. Kirkels, W.J. Zlotta, A.R. Boeve, E.R. Jöbsis, A.C. Kwast, Th.H. van der
2010-06-01
Controversies in the treatment of high-risk prostate cancer - What is the optimal combination of hormonal therapy and radiotherapy: A review of literature (Article)
Al-Mamgani, A. Lebesque, J.V. Heemsbergen, W.D. Tans, L. Kirkels, W.J. Levendag, P.C. Incrocci, L.
2010-05-15
Long-Term Efficacy Results of EORTC Genito-Urinary Group Randomized Phase 3 Study 30911 Comparing Intravesical Instillations of Epirubicin, Bacillus Calmette-Guérin, and Bacillus Calmette-Guérin plus Isoniazid in Patients with Intermediate- and High-Risk Stage Ta T1 Urothelial Carcinoma of the Bladder (Article)
Sylvester, R. Brausi, M.A. Reijke, T.M. de Kirkels, W.J. Hoeltl, W. Calais da Silva, F. Powell, P.H. Prescott, S. Kirkali, Z. Beek, C. van de Gorlia, T.
2010-05-01
CyberKnife stereotactic radiotherapy as monotherapy for low- to intermediate-stage prostate cancer: Early experience, feasibility, and tolerance (Article)
Aluwini, S. Rooij, P.H. van Hoogeman, M.S. Bangma, C.H. Kirkels, W.J. Incrocci, L. Kolkman-Deurloo, I.K.K.
2010-05-01
Total pelvic exenteration for primary and recurrent malignancies (Article)
Ferenschild, F.T.J. Vermaas, M. Verhoef, C. Ansink, A.C. Kirkels, W.J. Eggermont, A.M.M. Wilt, J.H.W. de
2009-07-01
The development of multiple bladder tumour recurrences in relation to the FGFR3 mutation status of the primary tumour (Article)
Kompier, L.C. Aa, M.N.M. van der Lurkin, I. Vermeij, M. Kirkels, W.J. Bangma, C.H. Kwast, Th.H. van der Zwarthoff, E.C.
2009-05-01
  • rss icon RSS Publication Feed
  • foaf icon FOAF Profile